Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for Chinese patients with squamous cell carcinoma of lung harboring EGFR mutation

OBJECTIVE: Epidermal growth factor receptor (EGFR) mutation mostly occurred in lung adenocarcinoma, rarely in squamous cell carcinoma (SQCC). EGFR mutation rate in SQCC varied in previous reports, and the efficacy of EGFR tyrosine kinase inhibitors (TKIs) in SQCC harboring EGFR mutation has not yet...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Fang, Wenfeng, Zhang, Jianwei, Liang, Wenhua, Huang, Yan, Yan, Yue, Wu, Xuan, Hu, Zhihuang, Ma, Yuxiang, Zhao, Hongyun, Zhao, Yuanyuan, Yang, Yunpeng, Xue, Cong, Zhang, Jing, Zhang, Li
Natura: Artigo
Lingua:Inglês
Pubblicazione: Pioneer Bioscience Publishing Company 2013
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3815724/
https://ncbi.nlm.nih.gov/pubmed/24255770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2013.09.15
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi